For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...
FAECAL microbiota transplantation (FMT) shows promise in treating ulcerative colitis (UC), with specific gut microbial ...
A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...
Sportico on MSN8h
Proposed Pharma Ad Ban May Be a Bitter Pill to Swallow for Sports TVThey dance in kitchens and in meadows frothy with flowers. They dance at weddings. They dance while fireworks bloom in dark ...
22h
Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever reported CDAI LDA response over 6 monthsFull clinical and ...
Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever reported CDAI LDA response over 6 monthsFull clinical and tr ...
The treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, ...
SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), today announced a major expansion to its Connect 360 Autoimmune Program, including the introduction of Stelara ...
That basic concept is why tons of people on social media are posting about a viral new product: Coconut Cult’s chocolate ...
Reported positive interim pharmacokinetic ("PK") and safety data in Phase 1 trial of SPY001 in November 2024 and strengthened the balance sheet with a $230 million ...
During respiratory illness season there a more graphic, yet shorter-lasting virus making the rounds especially among kids: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback